Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

August 2024

Indica Labs Announces Suite of HALO AI Apps to Power Life Sciences Image Analysis Workflows

2024-08-15T15:45:32+00:00

Indica Labs today announces expansion of AI capabilities for life science with the launch of HALO AI Apps, pre-trained tissue classifiers and cell phenotypers for tissue-based research applications. HALO AI Apps demonstrate powerful image analysis capabilities across a variety of tissue types out-of-the-box and can be further trained, tuned, and improved upon by customers with their own images and data. In total, 11 new apps are available with plans for further expansion.

Indica Labs Announces Suite of HALO AI Apps to Power Life Sciences Image Analysis Workflows2024-08-15T15:45:32+00:00

MedPath Achieves ISO 15189:2022 Certification for Digital Pathology Reporting

2024-08-15T08:34:57+00:00

Medica’s digital pathology reporting service, MedPath, has been officially certified to the ISO 15189:2022 standard. This certification represents a key milestone in Medica’s purpose of improving lives through excellence in diagnostics and research.

MedPath Achieves ISO 15189:2022 Certification for Digital Pathology Reporting2024-08-15T08:34:57+00:00

PathAI Announces Launch of AI-based Measurement of Metabolic Dysfunction-Associated Steatohepatitis (“AIM-MASH”) on the AISight Image Management System

2024-08-14T08:30:42+00:00

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, is proud to announce the launch of its AIM-MASH1 product on the AISightⓇ1 Image Management System (IMS). This product provides advanced AI-based measurement (AIM) to support the analysis of MASH Clinical Research Network (CRN) Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Activity Score (MAS) component grades and fibrosis staging. The launch of AIM-MASH on AISight aims to increase the reproducibility and scalability of pathologists' assessments and management of MASH cases, which are projected to reach 27 million in the US alone by 20302.

PathAI Announces Launch of AI-based Measurement of Metabolic Dysfunction-Associated Steatohepatitis (“AIM-MASH”) on the AISight Image Management System2024-08-14T08:30:42+00:00

Advancing Alzheimer’s Disease Studies Through High-throughput Digital Pathology: A Paradigm Shift

2024-08-12T13:08:07+00:00

In a new study, a multidisciplinary team of researchers at Rush University Medical Center (RADC) developed a digital pathology pipeline to assess Alzheimer’s disease pathologies, such as beta-amyloid plaques and tau neurofibrillary tangles.

Advancing Alzheimer’s Disease Studies Through High-throughput Digital Pathology: A Paradigm Shift2024-08-12T13:08:07+00:00
Go to Top